Log In
Print
BCIQ
Print
Print this Print this
 

Curaxin, quinacrine (CBLO102) (formerly CBLC102)

  Manage Alerts
Collapse Summary General Information
Company Cleveland BioLabs Inc.
DescriptionAnticancer compound from the Curaxin family that targets p53 and NF-kappa B (NF-kB)
Molecular Target NF-kappa B (NF-kB) ; p53
Mechanism of ActionNF-kappa B (NF-kB) inhibitor
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today